C81.7A
Other Hodgkin lymphoma, in remission
Clinical Classification Guidelines
Medical Intelligence & Overview
Other Hodgkin lymphoma in remission (ICD-10 code C81.7A) refers to a phase where a person who previously had Hodgkin lymphoma no longer exhibits signs of active disease. This condition indicates that treatments have been successful in reducing or eliminating detectable cancer cells, and the disease is currently not active. However, ongoing medical follow-up is important to monitor for any signs of recurrence. This guide provides an overview of this condition, its causes, symptoms, diagnosis, and general management considerations.
Causes & Symptoms
Clinical Causes: Hodgkin lymphoma is caused by abnormal growth of lymphocytes, a type of white blood cell involved in the immune response. The exact cause of Hodgkin lymphoma is unknown, but genetic factors, immune system deficiencies, and certain infections (like Epstein-Barr virus) may increase risk. Treatment with chemotherapy, radiation therapy, or a combination of both aims to eliminate cancer cells and induce remission.
Key Symptoms: Typically, in remission, there are no active symptoms related to Hodgkin lymphoma. Some individuals may experience fatigue or general weakness, which could be related to previous treatments or other health factors. There may be enlarged lymph nodes that are not causing discomfort and are considered residual or from previous disease rather than active lymphoma.
Diagnostic & Treatment
Diagnosis Path: Diagnosis of remission status is based on multiple follow-up assessments, including imaging tests such as PET scans, CT scans, and physical examinations to confirm the absence of active disease. Laboratory tests may also be conducted to track blood cell counts and overall health. The healthcare provider will evaluate these results to determine if the lymphoma remains in remission.
Treatment Protocols: While no active treatment is typically necessary during remission, ongoing follow-up care is essential. This may include periodic imaging, blood tests, and physical exams to monitor for any signs of recurrence. Patients are advised to maintain a healthy lifestyle, avoid exposure to infections, and report new or unusual symptoms promptly to their healthcare provider. In some cases, additional therapy might be considered if there is a relapse or progression of the disease.
Clinical Advice & FAQs
Billing Guidance
Is C81.7A a billable ICD-10 code?
Yes, C81.7A is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C81.7A?
Clinical documentation must specify the nature of Other Hodgkin lymphoma, in remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference